Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sabine Einhell
Observed names:
Einhell, Sabine,
S Einhell,
S. Einhell
Institution:
University Hospital Regensburg
Observed institutions:
University Hospital Regensburg,
Universitätsklinikum Aachen,
University of Regensburg,
RWTH Aachen University
ORCID:
0009-0000-1106-6548
Observed ORCID:
0009-0000-1106-6548
OpenAlex ID:
A5059873376
New Aspects of an Old Drug – Diclofenac Targets MYC and Glucose Metabolism in Tumor Cells
2013
·
Eva Gottfried
, Sven A. Lang
, et al.
·
PLoS ONE
·
133
PDF
Critical evaluation of molecular tumour board outcomes following 2 years of clinical practice in a Comprehensive Cancer Centre
2022
·
Alexander Scheiter
, Frederik Hierl
, et al.
·
British Journal of Cancer
·
34
PDF
Identification of Disparities in Personalized Cancer Care—A Joint Approach of the German WERA Consortium
2022
·
Florian Lüke
, Florian Haller
, et al.
·
Cancers
·
21
PDF
Primary and secondary metastatic dissemination: multiple routes to cancer-related death
2025
·
D. Sparrer
, R. Blazquez
, et al.
·
Molecular Cancer
·
19
PDF
Impact of neutropenia on central venous catheter–related bloodstream infections in patients with hematological malignancies at the time of central venous catheter insertion: A matched-pair analysis
2019
·
Daniela Tölle
, Marcus Hentrich
, et al.
·
Infection Control and Hospital Epidemiology
·
12
PDF
Systematic development of a patient-reported ONCOlogical-ROUTinE-Screening (ONCO-ROUTES) procedure at the University Cancer Center Regensburg
2024
·
Julia Maurer
, Anna Saibold
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
6
PDF
The WERA cancer center matrix: Strategic management of patient access to precision oncology in a large and mostly rural area of Germany
2024
·
Markus Krebs
, Florian Haller
, et al.
·
European Journal of Cancer
·
6
Entwicklung eines digitalen onkologischen Routinescreenings (ONCO-ROUTES) am Universitären Onkologischen Zentrum Regensburg (UCC-R)
2024
·
Julia Maurer
, Anna Saibold
, et al.
·
Die Onkologie
·
3
Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients
2026
·
Alexander Scheiter
, Simon Mellin
, et al.
·
BMC Medicine
·
2
Physical Performance, Sarcopenia and Malnutrition—Basic Test Set for Everyday Use in Cancer Therapy
2026
·
S. Einhell
, M. Albrecht
, et al.
·
Cancer Medicine
·
2
PDF
Preliminary effectiveness of social prescription and virtual patient information in increasing tertiary prevention among cancer patients (ESPRIT): protocol for a single-centre, randomised controlled pilot trial
2025
·
Lisa Boyer
, Christine Bernardi
, et al.
·
BMJ Open
·
1
PDF
Change in COVID-19 outcomes in lymphoma patients across pandemic waves: results of the COVID-19-lymphoma registry of the Bavarian Cancer Research Center (BZKF) 2020–2022
2026
·
Stefanie Forkl
, Felix Freudenberger
, et al.
·
Annals of Hematology
PDF
Shortening of central venous catheter time in men with hematological and oncological diseases for prevention of central venous catheter-related bloodstream infections: a target-trial-emulation study
2026
·
Oliver Kriege
, Boris Böll
, et al.
·
Infection
PDF
A multi-center cross-sectional study to explore cancer patients’ views on facilitators and barriers for the implementation of oncological exercise therapy
2026
·
Dominik Morlok
, Laura Bieniosek
, et al.
·
Frontiers in Oncology
PDF
Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients
2026
·
Scheiter, Alexander
, Mellin, Simon
, et al.
·
University of Regensburg Publication Server (University of Regensburg)
PDF
Additional file 1 of Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients
2026
·
Scheiter, Alexander
, Mellin, Simon
, et al.
·
Figshare
Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients
2026
·
Scheiter, Alexander
, Mellin, Simon
, et al.
·
Figshare
Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients
2026
·
Scheiter, Alexander
, Mellin, Simon
, et al.
·
Fraunhofer-Publica (Fraunhofer-Gesellschaft)
B-280 Nmr-based biomaker measurement determines high-dose methotrexate elimination rates in lymphoma and leukemia treatment
2024
·
A Robertson
, S Einhell
, et al.
·
Clinical Chemistry
A-126 Evaluation of NMR-based GFR Estimation in Dosing of High-dose Methotrexate
2023
·
A N Schwäble Santamaría
, S Einhell
, et al.
·
Clinical Chemistry
PDF
Regulation und Funktion des Onkogens MYC durch die nicht-steroidalen Antirheumatika Diclofenac und Diflunisal
2015
·
Einhell, Sabine
·
University of Regensburg Publication Server (University of Regensburg)
PDF
Stabilisierung von Noc4D6-8 aus Saccharomyces cerevisiae durch gerichtete Evolution
2007
·
Sabine Einhell
·
University of Regensburg Publication Server (University of Regensburg)
Show more works
View as search
Works count:
24
Citation count:
239
H-index:
6
I10-index:
5
Year
Topic
Type